Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota. 1982

G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov

Antiserum to the epimeraseless Rc mutant of Salmonella minnesota was prepared by immunization of rabbits. The antiserum provided good protection in mice i.p. challenged with 125 and 25 LD50 doses of live heterologous Gram-negative bacteria i. e. S. typhimurium, Escherichia coli and Pseudomonas aeruginosa. The protection against Klebsiella pneumoniae was negligible. Pre-immune rabbit serum produced only marginal protection. The protective effect of S. minnesota Rc antibodies was entirely abolished upon absorption of Rc antiserum with homologous bacteria. Pre-immune and absorbed sera exhibited a similar protective effect at lower LD50 values, namely 5 and 1 LD50.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females

Related Publications

G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
December 1974, Infection and immunity,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
March 1972, Journal of immunology (Baltimore, Md. : 1950),
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
November 1997, The Journal of infectious diseases,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
January 1985, Infection,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
April 1983, The New England journal of medicine,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
September 2017, International reviews of immunology,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
September 1973, Journal of bacteriology,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
November 1976, Immunology,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
December 2018, Microbial cell factories,
G Konstantinov, and M Karacholeva, and M Eskenazy, and R Ivanova, and J Vassileva, and F Naumova, and R Tekelieva, and D Strahilov
January 1989, La Tunisie medicale,
Copied contents to your clipboard!